A Systematic Approach for Scale-Down Model Development and Characterization of Commercial Cell Culture Processes
The DOI matches its Crossref record.
Abstract
The objective of process characterization is to demonstrate robustness of manufacturing processes by understanding the relationship between key operating parameters and final performance. Technical information from the characterization study is important for subsequent process validation, and this has become a regulatory expectation in recent years. Since performing the study at the manufacturing scale is not practically feasible, development of scale-down models that represent the performance of the commercial process is essential to achieve reliable process characterization. In this study, we describe a systematic approach to develop a bioreactor scale-down model and to characterize a cell culture process for recombinant protein production in CHO cells. First, a scale-down model using 2-L bioreactors was developed on the basis of the 2000-L commercial scale process. Profiles of cell growth, productivity, product quality, culture environments (pH, DO, pCO2), and level of metabolites (glucose, glutamine, lactate, ammonia) were compared between the two scales to qualify the scale-down model. The key operating parameters were then characterized in single-parameter ranging studies and an interaction study using this scale-down model. Appropriate operation ranges and acceptance criteria for certain key parameters were determined to ensure the success of process validation and the process performance consistency. The process worst-case condition was also identified through the interaction study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Self-citationFeeding lactate for CHO cell culture processes: Impact on culture metabolism and performance
Li, J., Wong, C. L., Vijayasankaran, N., Hudson, T., & Amanullah, A. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24389 · Cited by 137
“…achieve the same or similar pCO2 profiles across different scales, with larger scales typically having higher pCO2 levels due to differences in fermentor hydrostatic pressure, mixing, and CO2 stripping characteristics between small and large scale operations (Li et al., 2006; Mostafa and Gu, 2003).”
BackgroundXu, P., Clark, C., Ryder, T., Sparks, C., Zhou, J., Wang, M., Russell, R., & Scott, C. (2017) · Biotechnology Progress · doi:10.1002/btpr.2417 · Cited by 83
Scale‐Down Model Development in ambr systems: An Industrial Perspective
Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J. (2019) · Biotechnology Journal · doi:10.1002/biot.201700766 · Cited by 63
Nagashima, H., Watari, A., Shinoda, Y., Okamoto, H., & Takuma, S. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23744 · Cited by 52
Manahan, M., Nelson, M., Cacciatore, J. J., Weng, J., Xu, S., & Pollard, J. (2019) · Biotechnology Progress · doi:10.1002/btpr.2870 · Cited by 50
Tescione, L., Lambropoulos, J., Paranandi, M. R., Makagiansar, H., & Ryll, T. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25330 · Cited by 46
“This approach has been reported elsewhere for univariate analysis (Feng et al., 2006), and was applied here in an analogous manner.”
MethodHippach, M. B., Schwartz, I., Pei, J., Huynh, J., Kawai, Y., & Zhu, M. M. (2018) · Biotechnology Progress · doi:10.1002/btpr.2697 · Cited by 10
Metadata
- Authors
- Li, F., Hashimura, Y., Pendleton, R., Harms, J., Collins, E., & Lee, B.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2006-06-02
- Volume
- 22
- Issue
- 3
- Pages
- 696-703
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2162797636
- Cited by
- 110
- References
- 0
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.